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Mutations in an immunodominant CD8 CTL epitope (S-510-518) are selected in mice persistently infected with the
neurotropic JHM strain of mouse hepatitis virus. These mutations abrogate recognition by T cells harvested from the infected
CNS in direct ex vivo cytotoxicity assays. Previous reports have suggested that, in general, an oligoclonal, monospecific T
cell response contributes to the selection of CTL escape mutants. Herein, we show that, in MHV-JHM-infected mice, the CD8
T cell response after intraperitoneal infection is polyclonal and diverse. This diverse response was shown to include both
polyclonal and oligoclonal components. The polyclonal data were shown to fit a logarithmic distribution. With regard to
specificity, we used a panel of peptide analogues of epitope S-510-518 and spleen-derived CD8 T cell lines to determine why
only a subset of possible mutations was selected in persistently infected mice. At a given position in the epitope, the
mutations identified in in vivo isolates were among those that resulted in the greatest loss of recognition. However, not all
such mutations were selected, suggesting that additional factors must contribute to selection in vivo. By extrapolation of
these results to the persistently infected CNS, they suggest that the selection of CTL escape mutants requires the presence
of a monospecific T cell response but also show that this response need not be oligoclonal. © 1999 Academic Press
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tINTRODUCTION
In many viral infections, the host is unable to clear the
irus and the outcome is virus persistence. Since CD8
ytotoxic T cells (CTL) are critical for clearance of such
ntracellular pathogens as viruses, virus mutation result-
ng in the loss of T cell recognition would enhance
ersistence. CTL escape mutants were initially identified
n transgenic mice expressing a T cell receptor specific
or lymphocytic choriomeningitis virus (LCMV) after in-
ection with this virus (Pircher et al., 1990). They have
lso been identified in several human infections, includ-
ng those caused by Epstein–Barr virus, HIV-1, hepatitis B
irus, and hepatitis C virus (Bertoletti et al., 1994a,b; De
ampos-Lima et al., 1994; Franco et al., 1995; Klenerman
t al., 1994; McMichael and Phillips, 1997; Phillips et al.,
991; Price et al., 1997; Weiner et al., 1995; Wolinsky et al.,
996). It has been difficult in most of these infections,
owever, to prove that CTL escape mutants contributed
o virus persistence and that they were not selected as
n epiphenomenon. CTL escape mutants are not se-
ected unless the immune response to a specific epitope
s strong and functionally monospecific (Franco et al.,
995). If the response is polyspecific, as occurs in most
uman infections, mutation of a single CD8 T cell epitope
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Pediatrics, University of Iowa, Medical Lab-
ratories 2042, Iowa City, IA 52242. Fax: (319) 335-8991. E-mail: Stanley-eerlman@uiowa.edu.
042-6822/99 $30.00
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106ight not offer a significant advantage to the virus and as
consequence, CTL escape mutants would not com-
only be selected.
We have recently shown that CTL escape mutants
evelop at early times after infection in C57Bl/6 (B6) mice
nfected with the neurotropic JHM strain of mouse hep-
titis virus (MHV-JHM) (Pewe et al., 1996). In this model,
ice were infected intranasally in the suckling stage and
ere nursed by dams previously immunized to live MHV-
HM (Perlman et al., 1987). This regimen prevented the
cute encephalitis that invariably results from infection of
aive mice of all susceptible strains. However, virus was
ble to persist and 30–90% of animals later developed
indlimb paralysis with a chronic demyelinating enceph-
lomyelitis present on histological examination. Infec-
ious virus was isolated from all mice with hindlimb
aralysis. Analysis of the RNA isolated from this virus or
f RNA directly isolated from infected brains and spinal
ords showed that the immunodominant CTL epitope
residues 510–518 of the surface glycoprotein (epitope
-510-518)] (Bergmann et al., 1996; Castro and Perlman,
995) was mutated in nearly every sample that was
xamined. Mutations were detected in residues 2–7 of
he epitope, including residues important for binding to
he MHC molecule (positions 3 and 5) and recognition by
he T cell receptor (TCR) (positions 4 and 6). These
utations resulted in loss of recognition in direct ex vivo
ytotoxicity assays using lymphocytes harvested from
he central nervous system (CNS) of mice with acute
ncephalitis. No mutations were detected in the sub-
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107TCR DIVERSITY IN MHV CTL RESPONSEominant epitope recognized in this strain [residues
98–605 of the S glycoprotein (S-598-605)] nor in an
mmunodominant CD4 T cell epitope within the trans-
embrane (M) glycoprotein nor in any of the regions
lanking any of these epitopes (Pewe et al., 1996). These
utations in epitope S-510-518 were detected by 10–12
ays p.i. and their selection at early times suggested that
hey were involved in the process of persistence in B6
ice. Consistent with this, mutations were not detected
n the absence of an immune response since they were
ot observed in SCID mice (Pewe et al., 1997). They were
nly infrequently detected in mice that did not develop
indlimb paralysis, again suggesting that they played an
mportant role in persistence of infectious virus and the
evelopment of clinical disease (Pewe et al., 1996,1997).
n addition, infection of naive B6 mice with mutated virus
esults in more severe disease, with increased morbidity
nd mortality (Pewe et al., 1998).
In many cases in which CTL escape mutants have
een identified, monoclonal or oligoclonal expansions of
cells have also been reported (Callan et al., 1996;
alams et al., 1994; McMichael and Phillips, 1997; Pan-
aleo et al., 1994). Since different T cell clones specific for
single epitope should contact different residues on the
HC/peptide complex, development of CTL escape mu-
ants would be facilitated by or might require such a
imited T cell response. B6 mice infected with MHV-JHM
rovide an excellent model for assessing the require-
ent for an oligoclonal T cell response in the selection of
TL escape mutants. In addition, only a limited number
f possible mutations in epitope S-510-518 are selected
uring the course of persistence. This model system is
lso useful for investigating the basis of this preferential
election of some mutations.
RESULTS
ulk populations of epitope S-510-518-specific CD8 T
ells express several Vb chains
Thus far, only two CD8 T cell epitopes, S-510-518 and
-598-605, have been identified in B6 mice infected with
HV-JHM (Bergmann et al., 1996; Castro and Perlman,
995). As a preliminary screen for oligoclonal T cell
xpansion in infected mice, CD8 T cells isolated from the
NS of mice acutely infected with MHV-JHM were ana-
yzed for TCR Vb expression. These experiments re-
ealed no clear-cut monoclonal or oligoclonal response
n these mice with acute encephalitis (data not shown).
In the next set of experiments, the clonality of the
HV-specific response was examined in greater detail.
variety of experiments suggest that antigen inoculated
nto the brain parenchyma evokes an immune response
nly after reaching extraneural lymphatic tissue (Cserr
nd Knopf, 1992; Lynch et al., 1989; Stevenson et al.,
997a,b). Thus the response to MHV in the CNS reflects
he systemic immune response to the virus and should se similar to the response in other lymphatic tissue,
ncluding the spleen. The number of cells required for
everal of our experiments was larger than could easily
e obtained from the infected CNS for direct ex vivo
nalyses and lymphocytes harvested from the CNS are
ifficult to propagate ex vivo (Imrich et al., 1994; Irani et
l., 1997; Stohlman et al., 1993). For these reasons and
ince the splenic and CNS responses to MHV should be
imilar, bulk populations of spleen cells were used in
hese experiments instead of CNS-derived lymphocytes.
pleen cells from mice intraperitoneally infected with live
HV-JHM were used in these experiments because no
TL activity could be detected in splenocytes isolated
rom animals with acute encephalitis or chronic demy-
lination (Castro et al., 1994). Splenocytes were prepared
t 8 days p.i., stimulated with peptide S-510-518, and
nalyzed after short periods in culture to minimize any in
itro selection.
Initial experiments were directed at showing that
hese cells had the same specificity as lymphocytes
arvested from the CNS of mice with acute encephalitis.
or this purpose, the ability of these cells to respond in
TL assays to epitope S-510-518 and a previously char-
cterized panel of variant peptides was compared in
ose–response curves to that of CNS-derived lympho-
ytes analyzed directly ex vivo (Pewe et al., 1996). Previ-
usly, we showed that mutations in positions 4 and 6
CSLRNGPHL and CSLWNVPHL) resulted in a loss of
ecognition even at 1 mM concentrations of peptide us-
ng CNS-derived effector cells. Peptides with mutations
n positions 3, 5, and 7 (CSRWNGPHL, CSLWSGPHL, and
SLWNGLHL) were recognized at 1 mM but at least
00-fold more peptide was required for equivalent
mounts of lysis. When wild-type and these five variant
eptides were analyzed in cytotoxicity assays using
plenic T cells expanded in vitro for 3–4 weeks prior to
nalysis, all five mutations effectively abrogated recog-
ition (Fig. 1). Thus, these spleen-derived cells and cells
erived from the CNS of mice with acute encephalitis
esponded equivalently to epitope S-510-518 and its vari-
nts.
Next, Vb expression by bulk populations of spleen
ells was determined using three CTL lines (CTL-A,
TL-B, and CTL-C). Spleen cells were stimulated in vitro
or 2 weeks with peptide S-510-518. Stimulation for 2
eeks was chosen to minimize the introduction of a
ignificant bias resulting from propagation in vitro but
till allow sufficient time for selection and expansion of
ntigen-specific cells. At this time, .90% of the cells
ere CD81 by FACS analysis. Antigen specificity was
easured using an interferon-g (IFN-g) ELISPOT assay
Xue and Perlman, 1997). This assay was performed on
ach cell population after stimulation with peptide S-510-
18 and 64% of cells (range 50–72%) were antigen-spe-
ific. This number probably represents an underestimate
ince we found, using other CD8 T cell lines, that .95%
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108 PEWE AND PERLMANf CD8 cells were antigen-specific after 2 weeks in cell
ulture when assayed using MHC/peptide tetramers and
ACS. When TCR Vb usage was analyzed, each bulk
opulation consisted of cells expressing a diverse group
f Vb chains (Fig. 2). Although certain Vb chains, such as
b13, were overrepresented in all of the bulk popula-
ions, others, such as Vb5 and Vb6 in CTL-B and Vb4 in
TL-C, were prominent in only a single population.
lonal analysis also reveals a diverse immune
esponse
To characterize further the diversity of this response, T
ells were cloned at 14 days after harvest. T cell clones
ere then analyzed for TCR a and b chain usage. Each
chain consists of sequence encoded by variable (V),
iversity (D), joining (J), and constant (C) gene segments,
hereas the a chain includes sequences encoded by V,
, and C gene segments. As shown in Table 1, each clone
xpressed a unique pair of a and b chains with eight
ifferent Vb sequences detected among the 12 clones.
any clones expressed two rearranged a chains, in
FIG. 1. Cytotoxic response of spleen-derived lymphocytes to different
oncentrations of wild-type and variant peptides. Cells harvested from
he spleens of MHV-infected mice were stimulated in vitro with peptide
-510-518 and analyzed in cytotoxicity assays as described under
aterials and Methods. In each experiment, the amount of lysis ob-
erved for each concentration of peptide was standardized to the
mount of lysis observed with 1 nM wild-type peptide as described
nder Materials and Methods. The mean value for each concentration
f peptide was determined and the resulting dose–response curves
ere plotted as shown in the figure. Each peptide was analyzed in
hree to six individual experiments.greement with previous results (Casanova and Mary- anski, 1993), although it is not possible to determine from
hese data whether both encode functional protein.
According to X-ray crystallographic analysis of MHC/
eptide/T cell receptor interaction, the CDR3 loop of the
CR b chain directly interacts with peptide in the binding
roove of the MHC molecule and is therefore the most
mportant region of the TCR for antigen specificity (Gar-
ia et al., 1996). The CDR3 loop contains sequences from
he V, D, and J genes and is highly variable. In oligoclonal
cell responses, there is often conservation of not only
b usage, but also conservation of Jb usage, CDR3
ength, and even CDR3 sequence (Kalams et al., 1994;
aryanski et al., 1996; Pantaleo et al., 1994). Sequence
nalysis of the CDR3 region of the epitope S-510-518-
pecific clones revealed a diverse repertoire of Jb usage
ith eight different Jb elements represented. Each had a
nique CDR3 region. The antigen specificity of 11 of
hese T cell clones was determined using the variant
eptides described above and a peptide mutated in
osition 2, CFLWNGPHL, in dose–response curves. Vi-
us with the latter mutation has been identified in mice
hronically infected with MHV-JHM (Pewe et al., 1997).
he results of these experiments are shown in Fig. 3.
utations at positions 4 and 6 resulted in no recognition
ven at 100 nM peptide. Although there was some het-
rogeneity in the fine specificity of the response, muta-
ions in positions 2, 3, and 7 resulted in recognition only
t significantly higher concentrations of peptide than
equired for recognition of wild-type peptide. Peptide
SLWSGPHL was not analyzed in these studies since
his peptide is mutated in the anchor residue for binding
o the H-2Db molecule and binds to this molecule only at
igh concentrations (Pewe et al., 1996).
Oligoclonal T cell responses were identified in previ-
FIG. 2. Diverse TCR Vb usage is detected in epitope S-510-518-
pecific CD8 T cell lines. Bulk populations of CD8 T cells were pre-
ared from three groups of two to three mice and analyzed by FACS for
b usage as described under Materials and Methods. Samples ana-
yzed at 2 weeks after harvest are shown. Although some Vb elements,
uch as Vb13, were preferentially used in all three CTL lines, others
uch as Vb5, Vb6, and Vb9 were expressed to a higher extent in only
single cell line.
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109TCR DIVERSITY IN MHV CTL RESPONSEus studies because the majority of clones expressed a
ingle Vb and Jb region. Since a diverse population of Vb
egions were represented in the above T cell clones, it
as not possible to determine from these data whether
here was any preferential Jb usage within all those
lones expressing a specific Vb region. The assays de-
cribed above suggested that most cells in the bulk
opulations of splenocytes were antigen-specific after 2
eeks of in vitro culture. To determine whether there was
ny preferential usage of specific Vb–Jb pairs, the se-
uence of the CDR3 region in cDNA clones prepared
rom CTL-C (Fig. 2) and expressing TCR Vb4 and Vb13
hains was determined. These particular Vb regions
ere chosen because Vb13 is overrepresented in all
T
Sequence Analysis of TCR
Clone no. TCRVa TCRVb
1 (CTL-E)a 7 4
2 (CTL-A) 15,17 4
3 (CTL-A) 4 5
4 (CTL-E) 7,8 5
5 (CTL-A) 18 7
6 (CTL-A) 10 7
7 (CTL-D) 4,8 8
8 (CTL-A) NDb 8
9 (CTL-A) 4 11
0 (CTL-A) 1,8 10
1 (CTL-A) 8,10 13
2 (CTL-A) 10,13 16
Note. TCR usage determined by flow cytometry, reverse transcriptio
a Clones were prepared from three CTL lines (CTL-A, CTL-D, and C
b ND, Va usage could not be determined.
FIG. 3. Fine specificity of recognition of variant peptides by T cell
lones. The T cell clones shown in Table 1 were analyzed in cytotoxicity
ssays. For each experiment, the amount of lysis observed for each
oncentration of variant peptide was standardized to the maximal lysis
bserved with wild-type peptide for that clone. Each peptide was
nalyzed in two to five experiments. The mean value was determined
nd the resulting dose–response curves were plotted as in Fig. 1. The
mount of peptide required for 50% lysis was calculated from these
urves and the ratio of variant peptide to wild-type peptide required for
0% lysis is shown in the figure. u, 10–303 more peptide required; d,
0–1003; o, .1003; h, not reactive at 100 nM. The concentrations of
ild-type peptide required for half-maximal lysis ranged from 15 to 930oM. Clone 7 was not analyzed in these experiments. NT, not tested.hree populations of epitope S-510-518-specific T cells,
hile clones expressing Vb4 were selected to a much
reater extent only in CTL-C. These experiments assume
hat similar levels of T cell receptor mRNA are expressed
n individual cells and that the cDNA cloning steps do not
ntroduce a bias.
Analysis of these clones showed a striking difference
n oligoclonality between the Vb4- and the Vb13-express-
ng clones (Table 2). The Vb13 response was polyclonal,
nd although there was preferential usage of Jb2.6, most
lones expressed a unique CDR3 region. There was also
ittle conservation of CDR3 length since similar numbers
f clones expressing CDR3 regions of 7, 8, 9, 10, and 12
ucleotides were detected. The Vb4 response was oli-
oclonal, with the majority of clones expressing a single
b region and the same CDR3 region. One of the two
ominant clones was also detected in the analysis of T
ell clones shown in Table 1 (compare clone 1, Table 1,
nd clones Vb4-1 and Vb4-2, Table 2). The T cell clones
nd cDNA clones were isolated from different mice,
uggesting that in the context of Vb4 element usage, this
DR3 region was preferentially selected. These results
how that although the T cell response to epitope S-510-
18 is diverse, there is evidence for both a polyclonal and
n oligoclonal component within the response.
The Vb13 TCR data were further analyzed using sta-
istical methods originally developed for measuring the
bundance of species in a community when only a frac-
ion of all individuals are sampled. A variety of mathe-
atical models are available to explain such species–
bundance relationships (Krebs, 1989). The data were
mpirically determined to fit a logarithmic distribution
5 a(x 1 x2/2 1 x3/3. . .xn/n), in which S is the total
umber of sequences, a is the index of diversity of the
opulation, x is a constant related to the average number
Regions of T Cell Clones
CDR3 J Jb
SQDRGNNQAP LFG 1.5
SQGWGYNQDTQ YFG 2.5
SWDRGLGDTQ YFG 2.5
LRDNYAEQ FFG 2.1
ASSLVRGWEQ YFG 2.6
ASSLRASEV FFG 1.1
SDSDRGNQAP LFG 1.5
SARTNTGQL YFG 2.2
SFYYAGQ FFG 2.1
SHRDLFNERL FFG 1.4
SFYGGVQDTQ YFG 2.5
SLLGVGSAETL YFG 2.3
and DNA sequencing as described under Materials and Methods.ABLE 1
CDR3
V
CAS
CAS
CAS
CAS
C
C
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CAS
CAS
CAS
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n-PCR,
TL-E).f cDNA clones per sequence, ax is the number of
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110 PEWE AND PERLMANequences with one member predicted by the logarith-
ic series, ax2/2 is the number of sequences with two
ndividuals, etc. (Fig. 4). The logarithmic series for a set
f data is fixed by the number of sequences (S) and the
umber of individuals (N) in the sample. The relationship
etween these variables is
S 5 a loge~1 1 N/a! .
his equation can be used to estimate how many differ-
nt sequences are represented in the Vb13 population
Fisher et al., 1943). a is calculated to be 25.40 (standard
rror 0.30) and there are approximately 100,000–200,000
D8 T cells in the CNS of mice acutely infected with
HV-JHM. If 50% of these cells recognize epitope S-510-
18 (based on the presence of two CD8 T cell epitopes)
nd Vb13 cells represent 10% of the epitope S-510-518-
pecific cells, then approximately 10,000 Vb13 cells will
e specific for the epitope in an infected brain. Using the
nalyses described previously (Fisher et al., 1943), ap-
roximately 150 different TCR Vb13 sequences would be
redicted within this subpopulation.
orrelation between peptide recognition in CTL
ssays and selection of CTL escape mutants
Not all possible mutations in epitope S-510-518 are
T
Sequence Analysis of TC
Clone no. V CDR3
Vb13-1 AS SLGWGHGTEV
Vb13-2 AS RSGFSDY
Vb13-3 AS SSDNSGNTL
Vb13-4 AS RTTNYAQ
Vb13-5 AS SFSGQGPYYAEQ
Vb13-6 AS SFPDWGDNYAE
Vb13-7 AS SWDRGNTGQL
Vb13-8 AS SLDWGSAETL
Vb13-9 AS RGGGSMSRS
Vb13-10 AS SLAGQNTL
Vb13-11 AS SFGGLQNTL
Vb13-12 AS SFRGLNQDTQ
Vb13-13a AS SFYGDEQ
Vb13-14a AS SFYGDEQ
Vb13-15 AS SFPGQGKQ
Vb13-16 AS SLGGYYEQ
Vb13-17 AS SFPGYYEQ
Vb13-18 AS SLWGGANRQ
Vb13-19 AS SLGGIYEQ
Vb13-20 AS SFPGQYEQ
Vb13-21 AS SFYGSSYEQ
Vb13-22 AS SFPGSGEQ
Vb4-1a AS SQDRGNNQAP
Vb4-2a AS SQDRGNNQAP
Vb4-3 AS SQPGTVYAEQ
a Different sequence at nucleotide level, although same amino acid
b In one Vb4 cDNA clone, TCR b chain was not in-frame.elected during the course of persistence in B6 mice. Sne consequence of a polyclonal T cell response may
e that only certain mutations result in immune escape.
o determine whether this is the case, we developed a
anel of peptide analogues resulting from single nucle-
tide mutations in the wild-type RNA sequence. This
anel was chosen because variant epitopes resulting
FIG. 4. Frequency of TCR Vb13 T cell cDNA clones responding to
pitope S-510-518. The data shown in Table 2 for 35 clones are graphed
n this figure. Also shown is the predicted abundance of clones using
logarithmic series of values generated as described in the text. a 6
and Vb13 CDR3 Regions
J Jb Frequency
FFG 1.1 2/35
TFG 1.2 1/35
YFG 1.3 4/35
FFG 2.1 1/35
FFG 2.1 2/35
FFG 2.1 5/35
YFG 2.2 2/35
YFG 2.3 1/35
YFG 2.4 1/35
YFG 2.4 1/35
YFG 2.4 1/35
YFG 2.5 1/35
YFG 2.6 1/35
YFG 2.6 1/35
YFG 2.6 3/35
YFG 2.6 2/35
YFG 2.6 1/35
YFG 2.6 1/35
YFG 2.6 1/35
YFG 2.6 1/35
YFG 2.6 1/35
YFG 2.6 1/35
LFG 1.5 8/40b
LFG 1.5 1/40
FFG 2.1 30/40
ce.ABLE 2
R Vb4
Q
sequenE was calculated to be 25.40 6 0.30.
f
s
O
c
b
i
i
a
(
s
w
t
w
i
O
w
e
e
w
r
C
a
o
w
p
t
e
i
t
1
f
w
r
s
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
E
E
E
d
a
111TCR DIVERSITY IN MHV CTL RESPONSErom single nucleotide changes were more likely to be
elected in vivo than those requiring several mutations.
TABLE 3
Variant Peptide Concentration Required for Half-Maximal Lysis
Peptide Position
MHC or TCR
contacta
Concentration
(nM)b In vivo
SLWNGPHL Wild type 0.013
TLWNGPHL 2 MHC 0.036
PLWNGPHL 3.23 Yes
ALWNGPHL ,0.001
YLWNGPHL .100 Yes
CLWNGPHL 8.51
FLWNGPHL 75.9 Yes
SRWNGPHL 3 MHC .100 Yes
SIWNGPHL 0.002
SVWNGPHL 0.022
SFWNGPHL 3.31 Yes
SHWNGPHL 0.273
SPWNGPHL 0.059 Yes
SLGNGPHL 4 TCR .100
SLSNGPHL .100
SLLNGPHL .100
SLCNGPHL .100
SLRNGPHL .100 Yes
SLWHGPHL 5 MHC 2.24 Yes
SLWDGPHL 0.243 Yes
SLWTGPHL 2.99 Yes
SLWKGPHL 0.060
SLWSGPHL 36.5 Yes
SLWNRPHL 6 TCR .100 Yes
SLWNWPHL .100
SLWNEPHL 5.96
SLWNAPHL 23.7
SLWNVPHL .100 Yes
SLWNGLHL 7 MHC/TCR .100 Yes
SLWNGTHL 0.071
SLWNGAHL 0.032
SLWNGSHL 0.071
SLWNGHHL 0.750 Yes
SLWNGRHL .100
SLWNGPHH 9 MHC 0.119
SLWNGPHV 0.004
SLWNGPHS 0.154
SLWNGPHW 3.16
SLWNGPHP 0.546
CSWNGPHL Deleted 14.1 Yes
CFWNGPHL .100 Yes
CSLNGPHL .100 Yes
a Based on Hudrisier et al. (1995,1996); Young et al. (1994).
b The amount of peptide required for 50% lysis was calculated from
ose–response curves generated as described in the legend to Fig. 2
nd under Materials and Methods.nly mutations encoding residues 2–7 and 9 were in-luded in these analyses. Residues 2–7 were chosen
ecause mutations in these amino acids were identified
n viral isolates harvested from infected mice. Mutations
n residue 9 have not been detected, but since this amino
cid is believed to encode a secondary anchor residue
Falk and Rotzschke, 1993), changes in this amino acid
hould also affect recognition. This panel of peptides
as analyzed in cytotoxicity assays using bulk popula-
ions of spleen cells after stimulation in vitro for 2–3
eeks. In most cases, the mutations that were selected
n vivo were poorly recognized in these assays (Table 3).
f all the possible changes at a given residue, those that
ere selected were in general those requiring the larg-
st amount of peptide to sensitize cells for lysis. How-
ver, not all changes that resulted in a loss of activity
ere selected. For example, all mutations in position 4
esulted in a loss of activity, but only variant epitope
SLRNGPHL was detected in in vivo isolates (Pewe et
l., 1997).
The one apparent exception to the general rule that
nly changes that significantly diminished recognition
ere selected was the leucine to proline change at
osition 3. This variant was only slightly less efficient
han wild-type peptide in sensitizing cells for lysis. How-
ver, this mutation was never detected in infectious virus
solated from chronically infected mice. Rather, this mu-
ation was present in a minority of cDNA clones (1/10,
/8) prepared from infected spinal cord RNA harvested
rom two different mice and was detected in conjunction
ith other mutations in the epitope that decreased CTL
ecognition more completely (Pewe et al., 1997).
DISCUSSION
In B6 mice infected chronically with MHV-JHM, the
election of virus mutated in the immunodominant S-510-
TABLE 4
Primers Used for Vb Sequence Analysis
Vb2 CTG TTC ACT CTG CGG AGT CCT
Vb3 CAA GAA GTT CTT CAG CAA ATA GAC
Vb4 ACT TAT GGA CAA TCA GAC TGC CTC
Vb5 CCC AGC AGA TTC TCA GTC CAA C
Vb6 GAG ACT GAT CTA CTA TTC AAT AAC
Vb7 CCT GGT CTG GGG CTA CAG CT
Vb8 CAT GGG CTG AGG CTG ATC CAT T
Vb9 TGA TAA GAT TTT GAA CAG GGA AGC
Vb10 GCT ACA ATA ATA AGC AAC TCA TTG
Vb11 CAA GCT CCT ATA GAT GAT TCA GG
Vb12 CCT TAT GGA AGA TGG TGG GGC TT
Vb13 CCT AAA GGA ACT AAC TCC ACT CT
Vb14 CCA GGT AGA GTC GGT GGT GC
Vb15 TTT CTA CTG TGA ACT CAG CAA TC
Vb16 CAG ATG GAG TTT CTG GGT AAT TTC
Vb17 TGG TCA AGA AGA GAT TCT CAG CT
Vb18 CAT CTG TCA AAG TGG CAC TTC A
Vb19 AGA CAT CTG GTC AAA GGA AAA G.
Reverse primer was Cb: GCA ATC TCT GCT TTT GAT GGC TC
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112 PEWE AND PERLMAN18 epitope appears to be a major factor in virus persis-
ence and the subsequent development of clinical dis-
ase. The goal of the present set of experiments was to
etermine the clonality and specificity of the CTL re-
ponse to this epitope. Our experiments were performed
sing splenocytes from young adult mice infected intra-
eritoneally with MHV-JHM. These cells were analyzed
ecause no CTL activity was detected in the spleens of
ersistently infected mice and CNS-derived lymphocytes
re difficult to propagate in cell culture (Castro et al.,
994; Imrich et al., 1994; Irani et al., 1997; Stohlman et al.,
993). We assume, but have not formally shown, that CD8
cells are functionally and phenotypically similar in mice
nfected intraperitoneally and intranasally.
A polyclonal group of epitope-specific T cells would be
redicted to include cells able to interact preferentially
ith different subsets of MHC and peptide contact resi-
ues in the MHC binding groove. In this case, a single
mino acid change might cause a decrease in CTL
ecognition but would not lead to the development of CTL
scape mutants. On the other hand, an oligoclonal re-
ponse to a single epitope would facilitate selection of
TL escape mutants. Our results suggest that the oligo-
lonality or polyclonality of the T cell response matters
ess than the specificity of the response. The CTL re-
ponse to epitope S-510-518 is monospecific and conse-
uently, a single amino acid change results in CTL es-
ape.
The monospecificity of the CTL response is well illus-
rated in Table 3. Residues 4, 6, and 7 are predicted to
nteract with the T cell receptor (Hudrisier et al.,
995,1996; Young et al., 1994). Although individual
hanges in these residues might be predicted to have
ittle effect on a polyspecific CTL response, other studies
ave shown that TCR recognition is very sensitive to
hanges in these central amino acids of the epitope
Cole et al., 1995; De Campos-Lima et al., 1997; Janeway,
998). Consistent with these studies, all of the modifica-
ions to position 4 abrogated recognition as did many of
he changes at positions 6 and 7. Changes in positions 2,
, 5, and 7 are predicted to affect binding to the MHC
olecule and the mutations that were detected at posi-
ions 2, 5, and 7 in the in vivo isolates were shown by
thers (Hudrisier et al., 1996) to result in weak binding to
he H-2Db molecule. Three changes in position 3, an
uxiliary anchor residue, were detected in our in vivo
solates. We showed previously that one of these
hanges, Leu to Arg, decreased binding to the MHC
olecule and resulted in a loss of recognition by CNS-
erived lymphocytes (Pewe et al., 1996). The other two
hanges (Leu to Phe and Leu to Pro) are predicted to
ave less profound effects on binding (Hudrisier et al.,
996). These two mutations have strikingly different ef-
ects on T cell recognition (Table 4), suggesting that the
mino acids at this position in the epitope also interact
ith the T cell receptor. Both of these changes were setected in only a minority of cDNA clones prepared
rom RNA harvested from the CNS of chronically infected
ice and coexisted with other mutations with more pro-
ound effects on CTL recognition.
Not surprisingly, the mutations in epitope S-510-518
hat were selected in vivo nearly all result in significantly
educed ability to sensitize cells for lysis. What is less
lear is why only some of the mutations that caused a
ack of recognition were selected. Mutations in position
, a secondary anchor residue, should affect binding to
he MHC molecule and several of the mutations signifi-
antly affected CTL recognition. However, no mutations
n position 9 were observed in our previous studies
Pewe et al., 1997). These results suggest that only some
utations were tolerated in terms of RNA and protein
tructure.
Although an oligoclonal CD8 T cell response to spe-
ific viral epitopes has been reported in several cases,
articularly human patients infected with HIV-1 or Ep-
tein–Barr virus (Callan et al., 1996; Chen et al., 1995;
alams et al., 1994; McMichael and Phillips, 1997; Pan-
aleo et al., 1994), our results are consistent with other
eports in which a polyclonal response was identified.
ole et al. (1994) showed that murine TCR Vb usage by
D8 T cells responding to Sendai virus, a natural mouse
athogen, was extremely diverse, with multiple Vb and
b chains used. In most other reports, although a poly-
lonal response was identified, overexpression of a few
b elements was also detected. The CTL response to
nfluenza A and to HSV-1 in B6 mice was diverse, but
here was predominant usage of one and two TCR Vb
lements, respectively, in these animals (Cose et al.,
995; Deckhut et al., 1993). Similarly, a polyclonal re-
ponse with conservation of the CDR3 amino acid se-
uence was also reported in the human CTL response to
he influenza A matrix peptide M1(58-66) (Naumov et al.,
998). More recently, Sourdive et al. (1998) showed that
lthough several Vb chains were used by CD8 T cells
esponding to the immunodominant peptide of lympho-
ytic choriomeningitis virus in BALB/c mice, there was
referential usage of three Vb segments and overrepre-
entation of specific Vb chain CDR3 lengths within each
b population.
Our results show that a diverse T cell response to a
ingle epitope can have components of both an oligo-
lonal and a polyclonal response. TCR Vb4-expressing
D8 T cells comprise 25% of the total cells present in
TL-C at 12 days after harvest and stimulation in vitro
ith peptide S-510-518. This large Vb4 T cell response
as observed only in CTL-C and exhibited an extremely
imited repertoire of b chain expression (Table 2).
hether this oligoclonal response actually occurs in
ice or reflects preferential selection in vitro remains to
e determined. Sequence analysis of clones expressing
CR Vb13 elements revealed a much more diverse re-
ponse. Although most clones expressed a unique CDR3
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113TCR DIVERSITY IN MHV CTL RESPONSEegion and many Jb regions were used, the response
as not truly random since the Jb2.6 element was over-
epresented and there was evidence for some structural
onstraints in CDR3 expression. Thus in all the cDNA
lones expressing Jb2.4, Jb2.5, or Jb2.6, there was a
lycine positioned four residues after the V region-en-
oded serine (Table 2).
The distribution of cDNA clones expressing a Vb13
lement is well fit by a logarithmic series. An implication
f a logarithmic series is that the number of RNA species
epresented by a single TCR b element is maximal. The
ogarithmic series is an empirical description of the data
hat we have obtained, although it has been argued that
his series is useful for explaining distributions in which
single environmental factor was most important (May,
975). In our experiments, this factor would presumably
e binding to the MHC/peptide complex.
The next step will be to determine the relationship
etween TCR expression in the acutely or chronically
nfected CNS and the selection of CTL escape mutants.
ur results, using splenocytes, show that the CD8 T cell
esponse to epitope S-510-518 is sufficiently monospe-
ific to allow the development of CTL escape mutants.
sing MHC/peptide tetramer methodology (Altman et al.,
996), it will be possible to determine the specificity and
iversity of the T cell response to epitope S-510-518
sing cells harvested from the infected CNS.
MATERIALS AND METHODS
Animals. MHV-seronegative 5- or 6-week-old B6 mice
ere purchased from The Jackson Laboratories (Bar
arbor, ME) and the National Cancer Institute (Bethesda,
D). To obtain animals with acute encephalitis, mice
ere inoculated intranasally with 4 3 104 PFU wild-type
irus.
Cells and viruses. EL-4 (H-2b) cells were grown in
PMI medium supplemented with 10% fetal calf serum
nd antibiotics. MHV-JHM, used in all studies, was
rown and titered as previously described (Perlman et
l., 1987).
Development of T cell lines and clones. To develop
D8 T cell lines specific for epitope S-510-518, B6 mice
ere infected intraperitoneally (ip) with a sublethal dose
f MHV-JHM (2.5 3 105 PFU). Eight days later, spleno-
ytes from naive B6 mice were harvested and coated
ith a 0.1–1 mM concentration of peptide S-510-518 for
h at 37°C. After being washed, cells were irradiated
3000 rad) and mixed 1:1 with responder splenocytes
arvested from two (CTL-B, CTL-C) or three (CTL-A,
TL-D, CTL-E) immunized mice. Every 7 days thereafter,
iable cells were harvested, washed, and restimulated
ith irradiated splenocytes coated with peptide (0.1 mM).
ollowing the second stimulation, 5% rat concanavalin A
Con A)-stimulated splenocyte supernatant and 50 mM
-methyl-mannoside were added. Responder to stimula- Vor ratios were adjusted to 5 3 106 responder spleno-
ytes and 25–30 3 106 coated, irradiated stimulators per
-25 tissue culture flask.
After 2 weeks in culture, T cells were cloned at limiting
ilution in 96-well plates in medium containing 2–5 3 105
rradiated, peptide-coated spleen cells per well and 5%
at Con A supernatant. Clones became visible at 8–14
ays after seeding. Clones were propagated from dilu-
ions that showed less than 20% positive wells.
Cytotoxicity assays. Peptides were tested for their abil-
ty to sensitize EL-4 cells for lysis at the concentrations
ndicated in the figures. Peptides were synthesized by
hiron Mimotopes (Clayton, Victoria, Australia) using the
ultipin peptide synthesis system or synthesized by the
rotein Structure Facility at the University of Iowa using
anual solid-phase synthesis as previously described
Pewe et al., 1996). Peptides were resuspended in DMSO
nd dilutions prepared in sterile PBS. The peptides that
ere synthesized corresponded to variants of epitope
-510-518 that resulted from changing single nucleotides
n the RNA encoding the epitope. The only peptides not
ynthesized were CSLWYGPHL, CSLWIGPHL, CSLWNG-
HF, and CSLWNGPHM. Each peptide was analyzed in
hree to six experiments.
CD8 T cell lines were generated from the spleens of
ice intraperitoneally infected with MHV-JHM as de-
cribed above. After three or four rounds of stimulation,
ells were tested for their ability to lyse target EL-4 cells
oated with peptide in cytotoxicity assays as previously
escribed (Castro and Perlman, 1995). The effector to
arget ratio was 5:1. Average total release was 1650 cpm.
ackground lysis was ,10%. Data were normalized as
ollows. For each experiment, the amount of lysis ob-
erved with each concentration of peptide was normal-
zed to that observed with 1 nM wild-type peptide. The
alues for each individual concentration of peptide were
veraged. The mean value for each peptide then used to
enerate a master dose–response curve for that peptide.
he concentration of peptide required for half-maximal
ysis was determined from these curves.
FACS analysis. The TCR phenotypes of CD8 lympho-
ytes from T cell clones and lines were determined by
hree-color FACS analysis. Live cells were purified from T
ell clones and lines by centrifugation through His-
opaque 1083 (Sigma Chemical Co., St. Louis, MO). Cells
100,000–300,000) were first incubated with antibody to
he Fc receptor (mAb 2.4G2, provided by Dr. M. Dailey) in
at serum. This was followed by triple staining with a
ocktail of Cy5-conjugated antibodies to CD4 (GK1.5),
gM (B76), and Mac-1 (M1/70), FITC-conjugated anti-CD8
ntibody (Lyt-2) (all provided by Dr. M. Dailey), and bio-
inylated monoclonal anti-mouse Vb TCR antibodies
Vb2, B20.6; Vb3, KJ25; Vb4, clone KT4; Vb5.1, 5.2, MR9-4;
b6, RR4-7; Vb7 TR310; Vb8.1, 8.2, MR5-2; Vb9, R10-2;
b10b, B21.5; Vb11, RR3-15; Vb12, MR11-1; Vb13, MR12-3;
b14, 14-2, all purchased from Pharmingen, San Diego,
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114 PEWE AND PERLMANA). The cells were then incubated with phycoerythrin-
onjugated streptavidin. Propidium iodide was added
rior to analysis with a FACS Vantage (Becton Dickinson,
an Jose, CA).
Isolation of RNA from lymphocytes. RNA was isolated
rom lymphocytes using Tri Reagent (Molecular Re-
earch Center, Cincinnati, OH) according to the specifi-
ations of the manufacturer.
Sequence analysis. In all cases, cDNA was synthe-
ized from 2 mg lymphocyte RNA as previously described
Pewe et al., 1996). In the case of the T cell clones, Vb
sage was initially determined by FACS analysis. For
ach clone, Vb usage was confirmed by RT-PCR using
he primers listed in Table 4. PCR products were manu-
lly sequenced using the fmol DNA sequencing system
s recommended by the manufacturer (Promega, Madi-
on, WI). The same Vb primers that were used for PCR
ere also used for sequencing. Va usage was deter-
ined by RT-PCR using the primers listed in Table 5.
rimers for Vb detection were based on sequence infor-
ation provided by Dr. S. Miller, Northwestern University
Table 4). Primers for Va detection were modified ver-
ions of a previously published set of primers (Carson et
l., 1997) (Table 5).
For the synthesis of Vb4- and Vb13-specific cDNA
lones, the Vb4, Vb13, and Cb primers listed in Table 4
ere modified by the addition of GCG clamps and re-
triction sites to the 59 end (EcoRI site to the Cb primer
nd BamHI sites to the Vb primers). PCR products were
loned into pIBI31 (IBI, New Haven, CT) cut with the
ame enzymes. Clones were sequenced using the fmol
TABLE 5
Primers Used for Va Sequence Analysis
Va1 GCA GCA GAG CCC AGA ATC CCT C
Va2 TGA GAC AAA GTC CCC AAT CT
Va3 CCC AGT GGT TCA AGG AGT GA
Va4 GCA GAG GTT TTG AAG CTA CAT A
Va5 GTG GAG CAG CGC CCT CCT C
Va6 TGT AGC CAC GCC ACA ATC AGT GG
Va7 AGA AAG TGA TTC AGG TCT GG
Va8 TCA CAG ACA ACA AGA GGA CC
Va9 CCA GTT TCT CCT CAA ATA CAT C
Va10 AGT CCC GCG TCC TTG GTT CTG
Va11 GAA CAA AGG AGA ATG GGA GG
Va12 TGG TAC CGA CAG GTT CCC CAC C
Va13 GCA GGT GGA GCA GCT TCC TTC C
Va14 AGG TCT TGT GTC CCT GAC AG
Va15 AGA AGG TCG AGC AAC ACC AG
Va16 TGG TGA GTG GTC AAG CAA ACA C
Va17 GGA CTG TGT GTA TGA AAC CC
Va18 TCA GAG CCA CCC TTG ACA CCT CC
Va19 ATT TCT CCA CTT TCC TGA GCC GC
Va20 TGC CTG GTA CAA AAA ATA CCC TGA CAA C.
Reverse primer was Ca: GTC GGT GAA CAG GCA GAG GGT GNA sequencing system as described above with arimer complementary to the T7 polymerase sequence
TAATACGACTCACTATAGGG).
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